Loretta A. Williams
- Oncology top 5%
- Cancer survivorship and care 34
- Cancer Treatment and Pharmacology 26
- Hematology top 5%
- Multiple Myeloma Research and Treatments 21
- Chronic Myeloid Leukemia Treatments 18
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 8
-
- Childhood Cancer Survivors' Quality of Life 18
- Otorhinolaryngology top 5%
-
- Palliative Care and End-of-Life Issues 15
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Charles S. CleelandXin Shelley WangQiuling ShiTito R. MendozaGary M. MobleyZhongxing LiaoLi MaoAraceli García-González
- Cited by
- OncologyHematologyGenetics
- Journals
- Journal of Clinical Oncology (20 papers)Blood (17 papers)Supportive Care in Cancer (5 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Loretta A. Williams
113 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 132
- Oncology 863
- Hematology 352
- Genetics 183
- Pediatrics, Perinatology and Child Health 289
- Otorhinolaryngology 64
Countries citing papers authored by Loretta A. Williams
This map shows the geographic impact of Loretta A. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loretta A. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loretta A. Williams more than expected).
Fields of papers citing papers by Loretta A. Williams
This network shows the impact of papers produced by Loretta A. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loretta A. Williams. The network helps show where Loretta A. Williams may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Loretta A. Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 6 | |
| 11 | 2019 | 6 | |
| 12 | 2019 | 1 | |
| 13 | 2019 | 12 | |
| 14 | 2018 | 9 | |
| 15 | 2018 | 33 | |
| 16 | 2018 | 12 | |
| 17 | 2018 | 1 | |
| 18 | Recommendations for the Role of Clinical Pathways in an Era of Personalized Medicine | 2016 | 1 |
| 19 | 2016 | 55 | |
| 20 | 2006 | 58 |
About Loretta A. Williams
Loretta A. Williams is a scholar working on Hematology, Oncology and Otorhinolaryngology, having authored 119 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer survivorship and care (34 papers), Cancer Treatment and Pharmacology (26 papers), Multiple Myeloma Research and Treatments (21 papers), Childhood Cancer Survivors' Quality of Life (18 papers), Chronic Myeloid Leukemia Treatments (18 papers), Palliative Care and End-of-Life Issues (15 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Oncology (863 citations), Hematology (352 citations) and Genetics (183 citations). Loretta A. Williams has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Charles S. Cleeland, Xin Shelley Wang, Qiuling Shi, Tito R. Mendoza, Gary M. Mobley, Zhongxing Liao, Li Mao, Araceli García-González, Jörge E. Cortes and David Cella. Their work appears in journals such as Journal of Clinical Oncology, Blood, Supportive Care in Cancer, Gynecologic Oncology and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.